Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Study ID: NCT04521764
Start Date: 2020-09-23
End Date: 2027-08-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

54

Intervention / Treatment

Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein

Computed Tomography

Magnetic Resonance Imaging

Biopsy

Biospecimen Collection

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

Study ID: NCT06560398
Start Date: 2024-09-18
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

7649

Intervention / Treatment

Continuing Medical Education Events (CME)

Trial Connect Portal

Clinical Trial Newsletters

Implicit Bias Training

Recruitment Dashboard

Portfolio Profiles

Eligibility Calculator

Clinical Trial Education Sessions (Community Residents Only)

ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients)

New Patient Information (Moffitt Patients Only)

No Intervention

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Study ID: NCT03326921
Start Date: 2018-02-23
End Date: 2028-07-16
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR

Bone Marrow Aspiration

Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Study ID: NCT06218914
Start Date: 2024-03-22
End Date: 2043-11-18
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

NT-112: Autologous, engineered T Cells targeting KRAS G12D

AZD0240: Autologous, engineered T Cells targeting KRAS G12D

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

Study ID: NCT05716516
Start Date: 2023-05-04
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Estradiol

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Study ID: NCT06041516
Start Date: 2024-06-17
End Date: 2029-10-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

ADCT-701

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Study ID: NCT06799247
Start Date: 2025-05-06
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

100

Intervention / Treatment

Descartes-08

Placebo Drug

Sponsor

Cartesian Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

Study ID: NCT05417867
Start Date: 2021-04-14
End Date: 2027-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Biospecimen Collection

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Study ID: NCT07222436
Start Date: 2025-09-23
End Date: 2027-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment
Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Study ID: NCT07075471
Start Date: 2025-09-03
End Date: 2027-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Deciphera Pharmaceuticals, LLC

Source: clinicaltrials.gov

Share:
Add to list